With several oncology biosimilars expected to hit the U.S. market in the next few years, pharmaceutical drug manufacturers need clear insight into stakeholder perceptions and key drivers of adoption in order to thrive in a crowded and complex marketplace.
During this webinar, ZS and industry experts will discuss the following:
Contact us for more insights from ZS’s Biosimilar Adoption Study.